Cumberland Pharmaceuticals (CPIX) Reports Q1 EPS of $0.09
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of $0.09, versus $0.05 reported last year. Revenue for the quarter came in at $8.7 million, versus $8.1 million reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
